secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001906324-23-000052
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho preliminary Q3 revenue $738-744M; beats on early respiratory demand
-------------------------------------------------------------------------------

- Total revenue $738-744M vs prior expectations; non-respiratory $557-560M, respiratory $181-184M.
- Earlier-than-expected flu and COVID demand drove respiratory product sales higher in the quarter.
- Full-year 2023 guidance maintained: rev $2.88-3.08B, adj EPS $4.85-5.30, adj EBITDA $800-830M.
- All regions including China met or exceeded expectations; Q3 full results to be reported Nov 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000052/0001906324-23-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000052/qdel-20231012.htm
  HTML page:      https://secwatch.observer/filing/0001906324-23-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer